
Global Gene Expression Market Report and Forecast 2024-2032
Description
Global Gene Expression Market Report and Forecast 2024-2032
Global Gene Expression Market Report and Forecast 2024-2032
The global gene expression market size was valued at USD 13.3 billion in 2023. It is expected to grow at a CAGR of 10.4% during the forecast period of 2024-2032, driven by increasing investments in research and development by biotechnology and pharmaceutical companies across the globe. The market is experiencing robust growth and is expected to reach USD 32.4 billion by 2032.
Global Gene Expression Market Analysis
The global gene expression market is experiencing significant growth, fueled by advancements in genomic technologies and an increasing understanding of the genetic bases of diseases. Gene expression analysis involves examining the types and quantities of mRNA transcripts produced by genes in different cell types, providing insights into cellular functions and regulatory mechanisms. This analysis is crucial for understanding complex biological processes, diagnosing diseases, and developing targeted therapies. This market encompasses a range of products and services, including instruments, consumables, and software for gene expression profiling, as well as data analysis and interpretation services.
Global Gene Expression Market Dynamics
The market is driven by the expanding applications of gene expression studies in biomedical research, personalized medicine, and pharmaceutical drug development. Key factors propelling market growth include:
- Technological Advancements: Innovations in high-throughput sequencing technologies, microarrays, and bioinformatics tools have dramatically increased the efficiency, accuracy, and affordability of gene expression analysis.
- Increased R&D Investment: Rising investment in research and development by biotechnology and pharmaceutical companies, as well as academic and research institutions, is boosting demand for gene expression profiling.
- Growing Demand for Personalized Medicine: The shift towards personalized medicine, which uses individual genetic information to tailor medical treatment, is increasing the utilization of gene expression analyses to identify molecular markers and therapeutic targets.
Despite its potential, the gene expression market faces challenges, including:
- High Costs: The high cost of advanced gene expression analysis platforms and the need for specialized expertise can be barriers to adoption, especially in resource-limited settings.
- Data Complexity: The vast amount of data generated by gene expression studies requires sophisticated analysis tools and poses challenges in data interpretation and storage.
- Regulatory and Ethical Issues: Regulatory hurdles for the approval of gene-based diagnostics and therapies, along with ethical concerns related to genetic testing, can impact market growth.
The future of the gene expression market looks promising, with continuous advancements in technology and increasing applications in clinical diagnostics and therapeutic development. Emerging trends include:
- Integration of AI and Machine Learning: The integration of artificial intelligence (AI) and machine learning algorithms in data analysis is expected to enhance the interpretation of gene expression data, facilitating the discovery of novel biomarkers and therapeutic targets.
- Expansion into Emerging Markets: Growth opportunities in emerging markets, driven by improvements in healthcare infrastructure and increased healthcare spending, are likely to expand the global reach of gene expression analysis.
- Advancements in Single-Cell Analysis: Technological advancements in single-cell gene expression analysis are providing deeper insights into cellular heterogeneity, which is critical for understanding complex diseases and developing precision medicines.
Global Gene Expression Market Trends
The global gene expression market is witnessing rapid growth and evolution, driven by several key trends that underscore its impact on healthcare and research. These trends not only highlight the market's current dynamism but also point towards future directions in genomics and personalized medicine.
- Technological Advancements in Sequencing
- Expansion of Personalized Medicine
- Increase in Single-Cell Analysis
- Integration of AI and Big Data Analytics
- Growth in Cloud-based Solutions
- Regulatory and Ethical Developments
- Focus on Rare Diseases and Genetic Disorders
The global gene expression market is at the forefront of precision medicine and biomedical research, fueled by technological innovation, a deeper understanding of genetic variability, and the integration of computational tools. As the market continues to grow, these trends will shape the development of new diagnostics, therapeutics, and personalized treatment strategies, offering profound implications for patient care and health outcomes.
Global Gene Expression Market Segmentation
Market Breakup by Products and Services
- Consumables
- Instrument
- Services
Market Breakup by Technology
- Polymerase Chain Reaction
- Next Generation Sequencing
- DNA Microarray
- Others
Market Breakup by Application
- Disease Diagnosis
- Drug Discovery
- Drug Development
- Others
Market Breakup by End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institute
- Diagnostic and Clinical Laboratories
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Gene Expression Market Competitive Landscape
The competitive landscape of the global gene expression market is defined by the presence of leading companies such as Illumina Inc., Thermo Fisher Scientific, Promega Corporation, Revvity Inc., Agilent Technologies Inc., Oxford Nanopore Technologies Inc., F. Hoffmann La Roche Ltd., PacBio, QIAGEN, Bio-Rad Laboratories Inc., Danaher Life Sciences, and Takara Bio Inc. These key players are at the forefront of innovation, offering a broad spectrum of products and services that cater to the diverse needs of gene expression analysis. Their focus on R&D, coupled with strategic partnerships and acquisitions, drives the market forward by introducing advanced technologies and expanding their product portfolios. The competition among these firms is intense, fostering a dynamic market environment that continually enhances the capabilities and applications of gene expression analysis in research and clinical settings.
Key Questions Answered in the Report
- What is the current and future performance of the global gene expression market?
- What drives the growing demand for gene expression analysis?
- What are the main challenges facing the gene expression market?
- How have advances in sequencing technologies impacted gene expression analysis?
- How is gene expression research transforming the understanding of rare diseases?
- How is the global gene expression market segmented by products and services?
- How is the gene expression market segmented by application?
- Who are the key players in the global gene expression market?
- The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global gene expression market from 2017-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the global gene expression market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global gene expression industry and its attractiveness.
- The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Gene Expression Market Overview
- 3.1 Global Gene Expression Market Historical Value (2017-2023)
- 3.2 Global Gene Expression Market Forecast Value (2024-2032)
- 4 Global Gene Expression Market Landscape*
- 4.1 Global Gene Expression: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Gene Expression: Product Landscape
- 4.2.1 Analysis by Products and Services
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Application
- 5 Global Gene Expression Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Gene Expression Market Segmentation (2017-2032)
- 6.1 Global Gene Expression Market (2017-2032) by Products and Services
- 6.1.1 Market Overview
- 6.1.2 Consumables
- 6.1.3 Instruments
- 6.1.4 Services
- 6.2 Global Gene Expression Market (2017-2032) by Technology
- 6.2.1 Market Overview
- 6.2.2 Polymerase Chain Reaction
- 6.2.3 Next Generation Sequencing
- 6.2.4 DNA Microarray
- 6.2.5 Others
- 6.3 Global Gene Expression Market (2017-2032) by Application
- 6.3.1 Market Overview
- 6.3.2 Disease Diagnosis
- 6.3.3 Drug Discovery
- 6.3.4 Drug Development
- 6.3.5 Others
- 6.4 Global Gene Expression Market (2017-2032) by End User
- 6.4.1 Market Overview
- 6.4.2 Pharmaceutical and Biotechnology Companies
- 6.4.3 Academic and Research Institute
- 6.4.4 Diagnostic and Clinical Laboratories
- 6.4.5 Others
- 6.5 Global Gene Expression Market (2017-2032) by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Gene Expression Market (2017-2032)
- 7.1 North America Gene Expression Market (2017-2032) by Products and Services
- 7.1.1 Market Overview
- 7.1.2 Consumables
- 7.1.3 Instrument
- 7.1.4 Services
- 7.2 North America Gene Expression Market (2017-2032) by Application
- 7.2.1 Market Overview
- 7.2.2 Disease Diagnosis
- 7.2.3 Drug Discovery
- 7.2.4 Drug Development
- 7.2.5 Others
- 7.3 North America Gene Expression Market (2017-2032) by Country
- 7.3.1 United States of America
- 7.3.2 Canada
- 8 Europe Gene Expression Market (2017-2032)
- 8.1 Europe Gene Expression Market (2017-2032) by Products and Services
- 8.1.1 Market Overview
- 8.1.2 Consumables
- 8.1.3 Instrument
- 8.1.4 Services
- 8.2 Europe Gene Expression Market (2017-2032) by Application
- 8.2.1 Market Overview
- 8.2.2 Disease Diagnosis
- 8.2.3 Drug Discovery
- 8.2.4 Drug Development
- 8.2.5 Others
- 8.3 Europe Gene Expression Market (2017-2032) by Country
- 8.3.1 United Kingdom
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Others
- 9 Asia Pacific Gene Expression Market (2017-2032)
- 9.1 Asia Pacific Gene Expression Market (2017-2032) by Products and Services
- 9.1.1 Market Overview
- 9.1.2 Consumables
- 9.1.3 Instrument
- 9.1.4 Services
- 9.2 Asia Pacific Gene Expression Market (2017-2032) by Application
- 9.2.1 Market Overview
- 9.2.2 Disease Diagnosis
- 9.2.3 Drug Discovery
- 9.2.4 Drug Development
- 9.2.5 Others
- 9.3 Asia Pacific Gene Expression Market (2017-2032) by Country
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 ASEAN
- 9.3.5 Australia
- 9.3.6 Others
- 10 Latin America Gene Expression Market (2017-2032)
- 10.1 Latin America Gene Expression Market (2017-2032) by Products and Services
- 10.1.1 Market Overview
- 10.1.2 Consumables
- 10.1.3 Instrument
- 10.1.4 Services
- 10.2 Latin America Gene Expression Market (2017-2032) by Application
- 10.2.1 Market Overview
- 10.2.2 Disease Diagnosis
- 10.2.3 Drug Discovery
- 10.2.4 Drug Development
- 10.2.5 Others
- 10.3 Latin America Gene Expression Market (2017-2032) by Country
- 10.3.1 Brazil
- 10.3.2 Argentina
- 10.3.3 Mexico
- 10.3.4 Others
- 11 Middle East and Africa Gene Expression Market (2017-2032)
- 11.1 Middle East and Africa Gene Expression Market (2017-2032) by Products and Services
- 11.1.1 Market Overview
- 11.1.2 Consumables
- 11.1.3 Instrument
- 11.1.4 Services
- 11.2 Middle East and Africa Gene Expression Market (2017-2032) by Application
- 11.2.1 Market Overview
- 11.2.2 Disease Diagnosis
- 11.2.3 Drug Discovery
- 11.2.4 Drug Development
- 11.2.5 Others
- 11.3 Middle East and Africa Gene Expression Market (2017-2032) by Country
- 11.3.1 Saudi Arabia
- 11.3.2 United Arab Emirates
- 11.3.3 Nigeria
- 11.3.4 South Africa
- 11.3.5 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Partnership and Collaborations Analysis
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Illumina Inc.
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Thermo Fisher Scientific
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Promega Corporation
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Revvity Inc.
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Agilent Technologies Inc.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Oxford Nanopore Technologies Inc.
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 F. Hoffmann La Roche Ltd.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 PacBio
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 QIAGEN
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Bio-Rad Laboratories Inc.
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Danaher Life Sciences
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Takara Bio Inc.
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- List not exhaustive
- 18 Global Gene Expression Market – Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.